IMC Chicago’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

IMC Chicago’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$259K	Sell	1,558 -13,087	-89%	-$2.15M	﹤0.01%	4754
2025 Q4	$2.33M	Sell	14,645 -26,015	-64%	-$3.57M	﹤0.01%	2289
2025 Q3	$3.81M	Buy	+40,660	New	+$2.87M	﹤0.01%	1766
2023 Q4	–	Sell	-11,206	Closed	-$854K	–	1882
2023 Q3	$854K	Buy	11,206 +1,309	+13%	+$134K	﹤0.01%	1277
2023 Q2	$1.17M	Sell	9,897 -333	-3%	-$41.5K	﹤0.01%	1019
2023 Q1	$1M	Sell	10,230 -2,899	-22%	-$393K	﹤0.01%	1032
2022 Q4	$1.86M	Buy	13,129 +8,253	+169%	+$1.15M	﹤0.01%	831
2022 Q3	$684K	Buy	+4,876	New	+$894K	﹤0.01%	1033
2019 Q3	–	Sell	-1,421	Closed	-$1.43M	–	770
2019 Q2	$1.43M	Sell	1,421 -885	-38%	-$857K	﹤0.01%	482
2019 Q1	$2.76M	Buy	+2,306	New	+$2.4M	0.01%	322

Other funds holding LABU

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

IMC Chicago's LABU Position: Q1 2026 in Review

IMC Chicago reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 89% in Q1 2026, selling an estimated $2.15M and leaving 1,558 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #4754.

IMC Chicago first reported a position in LABU in Q1 2019 and has held it in 10 quarters since. The position peaked at $3.81M in Q3 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

IMC Chicago held 1,558 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $259K as of Q1 2026.
IMC Chicago sold 13,087 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $2.15M.
Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4754 holding.
IMC Chicago first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2019 and has held it in 10 quarters since.
IMC Chicago's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.81M in Q3 2025.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.